Advancements in Oncology panelist Margaret Gatti-Mays, MD, MPH, highlights the most pressing questions in breast cancer therapy. Dr. Gatti-Mays notes that chemotherapy and immunotherapy are used in the neoadjuvant triple-negative breast cancer setting, and a similar regimen is employed in the metastatic setting. She also discusses other viable therapy options.